ARTICLE | Financial News
ContraFect raises $12 million
October 27, 2010 12:02 AM UTC
ContraFect Corp. (New York, N.Y.) raised $12 million in a series B round led by Maxim Group. ContraFect is developing mAbs and lysins to treat infectious diseases. ...